OCT § * ong
Premarket Notification 510(k) Summary
CoolTouch LC215 Nd:YAG Laser System
This 510(K) Summary of safety and effectiveness for the Cool Touch LC215 Nd:YAG surgical
laser system is submitted in accordance with the requirements of 21CFR 807.92.

Applicant: New Star Lasers, Inc. dba CoolTouch, Inc.

Address: 9085 Foothills Boulevard
Roseville, CA 95747

Contact Person: Natalie R. Vollrath

Telephone: (916) 677-1900

Fax: (916) 677-1901

Preparation Date: August 27, 2007

Device Trade Name: CoolTouch LC215 Nd:YAG Surgical Laser

Common Name: Nd:YAG Pulsed Surgical Laser :

Classification Name: Instrument, Surgical Powered, Laser 79-GEX

Legally Marketed Predicate CoolTouch CT3S

Device: Nd:YAG Laser System

Description of the CoolTouch The LC215 Nd:YAG Laser System produces laser emission

LC215 Nd:YAG Surgical Laser: at 1320nm. The laser consists of three interconnected
sections: the cabinet which houses the power supply, the /
cooling system, the microcontroller and the laser, the fiber
optics, and the handpiece or JouleTracker

Intended use of the CoolTouch For use in dermatology for incision, excision, ablation and

LC215 Nd:YAG Surgical Laser: vaporization with hemostasis of soft tissue. For use in the
treatment of fine lines and wrinkles. For treatment of back
acne and atrophic acne scars. For treatment of reflux of the ‘
great and small saphenous veins associated with varicose
veins and varicosities

Performance Data: None

Conclusion: Based on the evaluation of the risks and hazards and
including various testing of the modifications, the
CoolTouch LC215 Nd:YAG Surgical Laser System is
substantially equivalent to the predicate device, the CT3S

- 4 DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service
mr Food and Drug Administration
9200 Corporate Boulevard
Rockville MD 20850
New Star Lasers, Inc. dba
CoolTouch, Inc.
% Ms. Natalie Vollrath
Quality Assurance Manager OCT 3° 2007
: 9085 Foothills Boulevard
Roseville, California 95747
Re: K072424
Trade/Device Name: CoolTouch LC215
Regulation Number: 21 CFR 878.4810
Regulation Name: Laser surgical instrument for use in general and plastic surgery and in
dermatology
Regulatory Class: II
Product Code: GEX
Dated: September 18, 2007
Received: September 19, 2007
Dear Ms. Vollrath:
We have reviewed your Section 510(k) premarket notification of intent to market the device
referenced above and have determined the device is substantially equivalent (for the indications for
use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce
prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that
have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic
Act (Act) that do not require approval of a premarket approval application (PMA). You may,
therefore, market the device, subject to the general controls provisions of the Act. The general
controls provisions of the Act include requirements for annual registration, listing of devices, good
manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it
may be subject to such additional controls. Existing major regulations affecting your device can
be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may
publish further announcements concerning your device in the Federal Register.
Please be advised that FDA’s issuance of a substantial equivalence determination does not mean
that FDA has made a determination that your device complies with other requirements of the Act
or any Federal statutes and regulations administered by other Federal agencies. You must comply
with all the Act’s requirements, including, but not limited to: registration and listing (21 CFR Part
807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the

Page 2 — Ms. Vollrath
This etter will allow you to begin marketing your device as described in your Section 510(k)
premarket notification. The FDA finding of substantial equivalence of your device to a legally
marketed predicate device results in a classification for your device and thus, permits your device
to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please
contact the Office of Compliance at (240) 276-0115. Also, please note the regulation entitled,
"Misbranding by reference to premarket notification” (21CFR Part 807.97). You may obtain other
general information on your responsibilities under the Act from the Division of Small
Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or
(240) 276-3150 or at its Internet address http://www.fda.gov/cdrh/industry/support/index.html.

Sincerely Nhe

tH \\ we {) fv

Mark N. Melkerson (Ly <p , | (war

Director () Gv

Division of General, Restorative

and Neurological Devices
Office of Device Evaluation
Center for Devices and
Radiological Health

Enclosure

510(k) Number Pending
Device Name CoolTouch LC215
Indications for The CoolTouch Model LC215 Nd:YAG Surgical Laser is
Use indicated for the following:
a) for use in dermatology for incision, excision, ablation and
vaporization with hemostasis of soft tissue;
b) for use in the treatment of fine lines and wrinkles;
c) for treatment of back acne and atrophic acne scars, and:
d) for treatment of reflux of the grédt and small saphenous
veins associated with varel eink\and varicosities.
(Division Sign-Off)
Division of General, Restorative,
and Neurological Vy,
510(k) wamber__|CO% v4
Prescription Use___X AND/OR Over-the-Counter Use
(Part 21 CFR 801 Subpart D) (21 CFR 801 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE ~ CONTINUE ON ANOTHER PAGE IF NEEDED)
eee
Concurrence of CDRH, Office of Device Evaluation (ODE)
Page _1_ of _1_

